MARKET

STIM

STIM

Neuronetics
NASDAQ
2.555
-0.185
-6.75%
After Hours: 2.549 -0.006 -0.23% 18:37 09/28 EDT
OPEN
2.700
PREV CLOSE
2.740
HIGH
2.710
LOW
2.540
VOLUME
941.81K
TURNOVER
--
52 WEEK HIGH
3.440
52 WEEK LOW
0.8000
MARKET CAP
194.68M
P/E (TTM)
-5.7989
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STIM last week (0914-0918)?
Weekly Report · 09/21 09:46
Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB)
TipRanks · 09/18 10:50
Weekly Report: what happened at STIM last week (0907-0911)?
Weekly Report · 09/14 09:49
B. Riley Securities Initiates Coverage of Neuronetics at Buy
NASDAQ · 09/11 23:43
Neuronetics a new buy at B Riley on interventional psychiatry platform
Seeking Alpha · 09/11 15:48
Neuronetics Initiated at Buy by B. Riley Securities
Dow Jones · 09/11 13:19
Neuronetics Price Target Announced at $5.00/Share by B. Riley Securities
Dow Jones · 09/11 13:19
B. Riley Securities Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5
Benzinga · 09/11 13:09
More
About STIM
Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.

Webull offers Neuronetics Inc stock information, including NASDAQ: STIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STIM stock methods without spending real money on the virtual paper trading platform.